SCHEMBL4498987

SCHEMBL4498987

CCC(C)CSCC(C)CC

nearest known ligand 0.33

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23127823 0.91
SCHEMBL22043072 0.88
SCHEMBL1704488 0.87
SCHEMBL22061042 0.84
SCHEMBL19166262 0.84 CYP3A4 (0.32) TSHR
SCHEMBL21180432 0.82
SCHEMBL7968694 0.82
SCHEMBL18773568 0.82
SCHEMBL1885347 0.82
SCHEMBL7968691 0.82

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118139694-A Grading system and application of hydrogenation catalyst and grading method of hydrogenation catalyst 中国石油化工股份有限公司 2024-06-04 CN disclosed
CN-116023988-B Hydrotreatment method of raw oil with high aromatic hydrocarbon content 中国石油化工股份有限公司 2024-05-03 CN disclosed
EP-3332006-B1 NOVEL ANTI-PD-L1 ANTIBODIES WUXI BIOLOGICS SHANGHAI CO LTD (CN) 2023-10-11 EP disclosed
CN-116020479-A Grading method of catalyst 中国石油化工股份有限公司 2023-04-28 CN disclosed
CN-116023988-A Hydrotreatment method of raw oil with high aromatic hydrocarbon content 中国石油化工股份有限公司 2023-04-28 CN disclosed
CN-116023986-A Hydrogenation pretreatment method 中国石油化工股份有限公司 2023-04-28 CN disclosed
CN-116023989-A Hydrogenation method 中国石油化工股份有限公司 2023-04-28 CN disclosed
CN-116020478-A Grading method of hydrotreating catalyst 中国石油化工股份有限公司 2023-04-28 CN disclosed
CN-116023987-A Hydrotreatment method 中国石油化工股份有限公司 2023-04-28 CN disclosed
EP-3660000-B1 METHOD FOR PRODUCING POLYTHIOL COMPOUND, METHOD FOR PRODUCING CURABLE COMPOSITION, AND METHOD FOR PRODUCING CURED PRODUCT HOYA LENS THAILAND LTD (TH) 2022-04-27 EP disclosed
US-7626044-B2 Triptolide derivatives and their uses SHANGHAI INSTITUTE OF MATERIA MEDICA CHINESE ACADEMY OF SCIENCES (CN) 2009-12-01 US disclosed
US-20070197476-A1 Triptolide Derivatives And Their Uses SHANGHAI PHARMACEUTICALS HOLDING CO., LTD. (CN) 2007-08-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070197476-A1 Triptolide Derivatives And Their Uses OXER1, CCRL2, OCIAD2 TSHR 321/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.